Iron chelation treatment of red blood cells infected with Plasmodium falciparum selectively intervenes with iron-dependent metabolism of malaria parasites and inhibits their development. Highly permeant hydroxamate iron chelator RSFi l eu,, affects all parasite stages when cultures are continuously exposed to drug, but affects primarily ring stages when assessed for irreversible effects, ie, sustained inhibition remaining after drug removal. On the other hand, the hydrophilic and poorly permeant desferrioxamine (DFO) affects primarily trophozoitelschizont stages when tested either in the continuous mode or irreversible mode. Unlike parasites, mammalian cells subjected to similar drug treatment show complete growth recovery once drugs are removed. Our studies indicate that parasites display a limited capacity to recover from intracellular iron depletion evoked by iron chelators. Based on these findings we provide a working model in which the irreversible effects of RSFs on rings are explained by the absence of pathways for iron UPPLY OF IRON in a nontoxic and bioavailable form is of paramount importance for cell survival. Unlike mammalian cells,'" malarial parasites sustain progressive intraerythrocytic growth and development independent of serum iron pools?" Although they engage in active digestion of host red blood cell ( B C ) hemoglobin?' it is not clear whether this mechanism generates the intracellular iron that furnishes vital iron-dependent functions. These functions involve key enzymes such as dihydroorate dehydrogenase for the synthesis of pyrimidines: ribonucleotide reductase (RNRase) for reduction of ribonucleotide diphosphates to deoxyribonucleotide triphosphates needed for DNA synthes i s ,~~,~~ mitochondrial enzymes for electron transport and adenosine triphosphate (ATP) formati~n,'~.'~ aconitase for tricarboxylic acid cycle and the translational regulation of iron protein expre~sion,'~''~ and hydrolytic phosphatases and transcription factors that modulate RNA synthesis.I6 Present information indicates that parasites lack heme oxygenases known to expedite heme-iron release in mammalian cell^^,'^ so that the bulk of iron derived from hemoglobin degradation sequestered in the insoluble parasite pigment, hemozoin, is probably not bioavailable. Thus, alternative mechanisms for iron mobilization would seem to be operative in parasites.
Iron chelation treatment of red blood cells infected with Plasmodium falciparum selectively intervenes with iron-dependent metabolism of malaria parasites and inhibits their development. Highly permeant hydroxamate iron chelator RSFi l eu,, affects all parasite stages when cultures are continuously exposed to drug, but affects primarily ring stages when assessed for irreversible effects, ie, sustained inhibition remaining after drug removal. On the other hand, the hydrophilic and poorly permeant desferrioxamine (DFO) affects primarily trophozoitelschizont stages when tested either in the continuous mode or irreversible mode. Unlike parasites, mammalian cells subjected to similar drug treatment show complete growth recovery once drugs are removed. Our studies indicate that parasites display a limited capacity to recover from intracellular iron depletion evoked by iron chelators. Based on these findings we provide a working model in which the irreversible effects of RSFs on rings are explained by the absence of pathways for iron UPPLY OF IRON in a nontoxic and bioavailable form is of paramount importance for cell survival. Unlike mammalian cells,'" malarial parasites sustain progressive intraerythrocytic growth and development independent of serum iron pools?" Although they engage in active digestion of host red blood cell ( B C ) hemoglobin?' it is not clear whether this mechanism generates the intracellular iron that furnishes vital iron-dependent functions. These functions involve key enzymes such as dihydroorate dehydrogenase for the synthesis of pyrimidines: ribonucleotide reductase (RNRase) for reduction of ribonucleotide diphosphates to deoxyribonucleotide triphosphates needed for DNA synthes i s ,~~,~~ mitochondrial enzymes for electron transport and adenosine triphosphate (ATP) formati~n,'~.'~ aconitase for tricarboxylic acid cycle and the translational regulation of iron protein expre~sion,'~''~ and hydrolytic phosphatases and transcription factors that modulate RNA synthesis.I6 Present information indicates that parasites lack heme oxygenases known to expedite heme-iron release in mammalian cell^^,'^ so that the bulk of iron derived from hemoglobin degradation sequestered in the insoluble parasite pigment, hemozoin, 8, 10 acquisition/utilization by early forms of parasites. Trophozoite/schizonts can partially recover from RSFi l eu,, treatments, but show no DNA synthesis following DFO treatment even after drug removal and iron replenishment by permeant iron carriers. At trophozoite stage, the parasite uses a limited pathway for refurnishing its iron-containing enzymes, thus overcoming iron deprivation caused by permeant RSFileu&, but not by DFO because this latter drug is not easily removable from parasites. Their DNA synthesis is blocked by the hydroxamate iron chelators probably by affecting synthesis of ribonucleotide reductase (RNRase). Presumably in parasites, prolonged repression of the enzyme leads also to irreversible loss of activity. The action profiles of RSFi l eu,, and DFO presented in this study have implications for improved chemotherapeutic performance by combined drug treatment and future drug design based on specific intervention at parasite DNA synthesis. is probably not bioavailable. Thus, alternative mechanisms for iron mobilization would seem to be operative in parasites.
Previous studies have shown that the iron-chelating agent desferrioxamine (DFO) acted as a reversible and nontoxic S-phase inhibitor of lymph~id''.'~ and leukemia cell proliferation by blocking DNA synthesis as a result of limiting the iron supply to RNRase." Moreover, chelator-mediated removal of iron from Herpes simplex virus2' or Escherichia coli RNRase under more stringent chemical conditions showed that loss of enzyme activity was commensurate with drug-induced iron d e f i~i t .~~*~~ Because malaria parasites and mammalian cells apparently differ in their routes of iron acquisition, it might be possible to apply iron-chelation therapy as a means to selectively intervene with the parasite's iron-dependent metabolism. Our previous studies with lipophilic and hydrophilic siderophores indicated that their inhibitory potency reflected the chemical properties of the drugs in relation to the membrane barriers they need to cross in order to reach the biologic
In this work we assess the parasite's capacity to recover from chelator treatment after drug removal. We reasoned that such treatment with lipophilic (so-called reversed siderophores [RSFs] ) should lead to rapid depletion of parasite iron stores by fast access to parasite compartments, sequestering iron and exit from the cells.26 However, the residual effects on parasites would also depend on the parasite's capacity to restore iron stores and iron-dependent functions. Thus, similar treatment with more hydrophilic drugs such as DFO, which is markedly slower in permeating across membrane^,^^*^^ should cause more sustained effects because of their prolonged retention in parasite compartments. The main property followed in this work is that of DNA synthesis, based on the known iron-chelator effects on other cells, primarily on the iron-containing enzyme RNRase. The trophozoitelschizont stages were chosen for this assessment because at these stages peak activity of the parasite's RNRase has been implied.'n~27~30 The findings presented here indicate that malaria parasites markedly differ from mammalian cells in their mode of recovery from drug- induced iron depletion. These differences provide the basis for the selective antimalarial activity of the iron chelators used and for design of improved chemotherapy. Microcultures of parasitized RBCs in 24-well plates were washed three times in 2.5 mL of medium without plasma to remove the free radiolabeled nucleotides. The washed cells were then lysed in 2 mL of hypotonic detergent buffer of 2% Triton X-100 in 50 mmovL EDTA, 10 mmoY L TRIS-HCL, 200 pg/mL protease K, and 15 pg/mL of herring sperm DNA, pH 7.4. The lysate was incubated overnight at 37°C and treated with 5% trichloro-acetic acid (TCA). The precipitate was washed three times in 2 mL of ice-cold TCA (5%) and incubated for 16 hours at 37°C in 0.3 N KOH+ 50 mmovL EDTA to hydrolyze the RNA. The DNA was recovered by TCA precipitation and transfer of the pellet to Whatmann 25-mm glass fiber filters (Tamar, Jerusalem) by six to seven successive washes in 5 mL TCA (5%).
MATERIALS AND METHODS

Materials
Measurements of ATP production. Trophozoite-infected RBCs were separated from cultures by centrifugation through isopycnic Percoll (Pharmacia, Uppsala, Sweden) gradient as described elsewhereM and treated with iron chelators in growth medium supplemented with 20 mg/mL glucose. The ring-infected cells were treated with iron chelators in cultures synchronized by l-alanine method and subsequent separation on Percoll gradient. ATP levels were measured in the 5% TCA soluble fraction of freeze-thaw lysates of whole-cell pellets using the luciferin-luciferase bioluminescence assay.35
RESULTS
We have shown in a previous study that RSFileu,,, like DFO, affected parasite and mammalian cell development by chelating intracellular iron." These effects were fully abrogated if chelators were precomplexed to iron(II1). Based on the documented iron(II1) chelation from cells in culture by DFO and RSFileu,,, we considered first the possibility that inhibition of parasite growth was associated with effects on energy production, based on the propensity of metal chelators to interact with the Fe-0 bonds of iron-containing enzymes. For that purpose we measured the ATP levels of rings and trophozoitelschizonts after 5 hours of exposure to 100 pmol/L RSFileu,, or DFO. These treatments were previously shown to cause 50% to 60% inhibition of parasite growth in rings by RSFileu,, and in trophozoites by either RSFileu,, or DF0.26 With the exception of RSFileum2 in trophozoites, the results in Table 1 indicate that energy supply of parasites was not substantially reduced by the iron chelators. The 32% reduction in ATP level by RSFileu,, treatment when compared with the 85% reduction by rotenone indicates that iron chelation causes at most a partial inhibition of parasite ATP production.
Efsects of iron chelators and hydroxyurea (HU) on the nucleic acid andprotein synthesis of malaria parasites. Preliminary experiments with the iron chelators RSFileum2 and DFO and the free radical scavenger and known inhibitor of RNRase HU indicated that DNA synthesis was reversibly affected by continuous exposure to these agentsz4 (and unpublished observation, December 1993). However, the pattern of inhibition of parasite functions (trophozoite stage) by the inhibitors (Fig 1) diverged from that found in mammalian cell cultures only in the irreversible mode of action of iron chelators. DNA synthesis was the major synthetic function affected during continuous exposure of trophozoites to either drug and was also the function that demonstrably recovered after removal of the RNRase inhibitor HU. However, partial (for RSFileu&) or no reversal (for DFO) of nucleic acid synthesis was observed after iron chelators were applied to infected cells and subsequently removed (Fig l) . The DFOtreated parasites remained growth arrested at the trophozoite stage as visualized by morphology in Giemsa-stained slides (results not shown). The level of DNA synthesis was reduced under continuous exposure of cells to the highly membrane permeant and fast-acting RSFileu,, but increased after drug removal. When trophozoites were treated with slow-permeating DFO, the DNA synthesis was reduced to 12% to 28% of the control, irrespective of continuous exposure or drug removal. This irreversible pattern of inhibition was also found on trophozoite total nucleic acid synthesis. The extent of inhibition after exposure to DFO was greater than after the exposure to RSFileu,,: for DFO the level of nucleic acid synthesis was 25% of control and for RSFileu,, 80% of control (Fig 1) . The irreversible effects of RSFileu,,, which a limited capacity for restoring depleted iron stores or for functionally integrating iron into enzymes. An attempt was made to overcome the purported limitations in iron acquisition by supplying iron via permeating iron-complexes acetoacetonate iron (AA-Fe) and NTA-Fe.36 Such complexes can provide metabolically essential iron to mammalian cells in culture grown in transferrin-free media." However, in chelator-treated parasites no recovery was found probably because of inability to use iron but not because of lack of penetration of the iron (111) carrier or iron per se into infected R B C S~~ (and not shown).
Stage dependence of USFileumZ and DFO: irreversible effects. The antimalarial action of DFO and RSFileu,, was further assessed by exposing either rings or trophozoites to drugs for different periods of time and measuring nucleic acid synthesis after drug removal (Fig 2) . The iron chelators differed in the mode they irreversibly inhibited rings and trophozoites. During the ring stage, irreversible inhibition we originally reported on trophozoite-stage cultures," represented the action profile of the first synthesized batches of drug. In subsequent testing of six different batches, we found that RSFileum2 effects on trophozoites were quantitatively the same to the original samples when tested on cells under continuous exposure. However, on removal of drug, the inhibitory effects were consistently reversible in trophozoites, attaining 70% to 90% of the control level and virtually irreversible in rings (10% to 30% of the control).
The partial reversibility or irreversibility of the iron-chelator treatment of parasitized cells indicates that parasites have 
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by RSFileu,, was considerably greater than that caused by DFO, even though the latter was used at threefold higher concentrations than RSFileu,, . We attributed the poor effect of DFO to poor penetration, as indicated p r e v i o~s l y . '~~~~ However, during the trophozoite stage, the inhibitory pattern was inverted as the irreversible inhibition caused by DFO became considerably greater than that caused by RSFileu,, .
DISCUSSION
Organisms use different pathways for the mobilization/ utilization of iron and its storage in a nontoxic and bioavailable form. For example, bacteria, fungi, and plants have adapted to limited iron environment by synthesis of siderophores of high affinity and low molecular weight that capture iron outside the cell and deliver it via specific receptormediated uptake.' Mammalian cells respond to changes in iron levels and regulate their iron balance through transcriptional and translational control over expression of storage protein ferritin and receptors for transferrin.'vz
The host-parasite interplay in malaria would seem to present a special case of iron acquisition and utilization. Unlike mammalian cells that acquire their iron primarily from transferrin,' parasites mobilize their iron from inside the infected RBC. 4, 6 This difference provided the basis for selective intervention with iron chelators.
The iron chelators applied in this work are of the hydroxamate type, whose properties are favorable for scavenging cellular in contrast to others that remove iron also from t r a n~f e n i n .~~ The effects of RSFileu,, and DFO on DNA synthesis of mammalian cells were of a fully reversible nature. The reversibility properties confirm previous studies in and leukemia cells with DFO," which showed that both DNA synthesis and RNRase activity were reduced by DFO and then restored on subsequent addition of serum iron source. Plasmodium falciparum-infected cells showed a different pattern of susceptibility to iron-chelation treatment. Parasites were vulnerable to the antiproliferative and cytotoxic action of iron chelators in conditions of continuous exposure to drugs but, most importantly, showed variable capacity for recovery after drug removal depending on the drug properties (eg, permeation), the drug treatment (concentration and exposure time), and the developmental stage of the parasite. The irreversible mode of action of iron chelators was manifested to the greatest extent as DFOmediated blockage of DNA synthesis at the trophozoite stage and as RSFileu,, blockage of nucleic acid synthesis at the ring stage. Our original work with RSFileu,, on the mature stages of parasite growth indicated an irreversible mode of action, similar to that of DFO." However, all subsequent work with six new batches of the drug showed that the effects of RSFileu,, were demonstrably irreversible in rings and partially irreversible in trophozoites (Fig 2) . The degree of reversibility found in trophozoites varied with the abovementioned parameters.
Interestingly, malaria parasites failed to recover from chelation treatment even when resupplied with a surplus of iron in the form of iron salts or hydrophobic iron carrier complexes such as NTA-Fe or AA-Fe. Because these iron complexes are demonstrably permeant to host and parasite membranes and replenish cell iron (111), they would be expected not only to neutralize residual iron chelators by formation of nontoxic iron complexes,2433o but also to supply iron and reverse chelator-induced inhibition. No such reversal occurred despite the fact that approximately 20% to 30% of the iron taken up by the infected cells was found associated with the parasite itself. The ostensible lack of reversal of DFO-treated trophozoites on iron restoration indicates that the chelators interfere either directly or indirectly with generation or reconstitution of iron-dependent functions, but not necessarily with iron acquisition per se. This finding is consistent with evidence that iron chelators act not by iron removal from fully assembled RNRase iron protein but rather by blocking iron integration into newly synthesized R2 subu n i t~.~~ Although, like all other organisms, parasites are likely to use enzymatic pathways for functional integration of the metal in iron-containing enzymes, such pathways might be absent in rings, thus rendering them vulnerable to RSFs, and might operate only at low capacity in trophozoites, thus rendering them susceptible to DFO.
In our previous study on RSFileu,, and DFO permeation into parasites and cytotoxic activity, we proposed that these drugs irreversibly block the parasite metabolic activity by reaching intraerythrocytic targets and inducing an iron deficit that parasites have a restricted capacity to restore. 26 The differential drug sensitivity of rings and trophozoites can be attributed to the drugs' different permeation properties. 26 In LYrrON ET AL ciated with differential permeation of drugs into rings and trophozoites. DFO penetrates the parasite best at trophozoites where it is subsequently retained after washes. 25 The consequence of this retention is irreversible block of DNA synthesis either by direct interaction of DFO with RNRase's iron center" or its intervention with iron mobilization needed for functional assembly of this enzyme and possibly other iron-dependent activities. RSFileu,:, permeates into rings and trophozoites but acts irreversibly primarily at the ring stage. The considerably lower irreversible effects of RSFileum2 on trophozoites relative to DFO (Fig 2) presumably result from the fact that free and iron-complexed RSFileum2 can exit the infected cell during washesz6 and allow the parasite to restore iron-dependent functions. The active phase of iron mobilization by the parasite would thereby seem to span a fraction of the trophozoite stage. Thus, the irreversible mode of action of iron chelators would seem to be intimately associated with their permeation properties and the mode of iron mobilizatiodutilization by intracellular parasites. Future studies aimed at further understanding of iron chelator mode of action on Plasmodium DNA synthesis would need to resolve the question of whether or not the drugs actually affect iron supply or activity of the parasite RNRase inside infected RBCs.
